Clinical Trial Update: Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating carboplatin plus paclitaxel with or without continued low-dose paclitaxel in early-stage ovarian cancer completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-04-17